Table 2.

Stratified analyses for association between PA trajectory group and incident T2DM.

Subgroups	PA trajectory group				P for trend
	Consistently low	Single peak	Double peak	Intense
Age
<65	1 (reference)	0.80 (0.71–0.89)	0.61 (0.52–0.72)	0.49 (0.41–0.58)	2.43E-19
≥ 65	1 (reference)	0.74 (0.63–0.88)	0.59 (0.41–0.84)	0.49 (0.35–0.68)	1.52E-06
Sex
Men	1 (reference)	0.80 (0.71–0.89)	0.54 (0.45–0.65)	0.44 (0.37–0.54)	8.76E-20
Women	1 (reference)	0.76 (0.65–0.88)	0.70 (0.56–0.88)	0.54 (0.43–0.69)	9.55E-07
BMI
< 25	1 (reference)	0.66 (0.48–0.90)	0.63 (0.42–0.93)	0.52 (0.36–0.75)	3.42E-03
≥ 25	1 (reference)	0.78 (0.71–0.85)	0.59 (0.51–0.69)	0.47 (0.40–0.56)	2.46E-22
eGFR
< 60	1 (reference)	0.71 (0.44–1.14)	0.33 (0.10–1.13)	0.26 (0.08–0.86)	7.05E-03
≥ 60	1 (reference)	0.78 (0.71–0.86)	0.61 (0.53–0.71)	0.49 (0.42–0.57)	2.61E-23
CRP
< Median	1 (reference)	0.64 (0.54–0.77)	0.48 (0.37–0.63)	0.41 (0.32–0.54)	7.44E-12
≥ Median	1 (reference)	0.82 (0.74–0.92)	0.68 (0.57–0.80)	0.54 (0.45–0.64)	9.77E-13
CVD history
No	1 (reference)	0.75 (0.68–0.83)	0.57 (0.49–0.67)	0.47 (0.40–0.55)	8.19E-22
Yes	1 (reference)	0.84 (0.70–1.01)	0.73 (0.53–1.01)	0.51 (0.36–0.72)	1.31E-04
Cancer history
No	1 (reference)	0.77 (0.69–0.84)	0.59 (0.51–0.68)	0.48 (0.41–0.56)	9.25E-23
Yes	1 (reference)	0.87 (0.67–1.14)	0.73 (0.48–1.11)	0.48 (0.30–0.78)	2.43E-03